This study attempted to fill the dearth of literature establishing the repeatability of DWI and DCE-MRI using a population of non-progressing men on active surveillance for prostate cancer. MRIs from men (n=26) with two DCE-MRI scans in one year were examined and mean ROI values on different imaging maps were analyzed for percent repeatability coefficient (%RC). %RC was lowest for ADC, DCE MRI peak enhancement, T2-weighted images and pharmacokinetically modeled ve and Ktrans.
This abstract and the presentation materials are available to members only; a login is required.